PAYMENT FOR INHALATION DRUGS.

SEC. 305. PAYMENT FOR INHALATION DRUGS.(a) In General.—Section 1842(o)(1)(G) (42 U.S.C. 1395u(o)(1)(G)), as added by section 303(b), is amended to read as follows:“(G) In the case of inhalation drugs or biologicals furnished through durable medical equipment covered under section 1861(n) that are furnished—“(i) in 2004, the amount provided under paragraph (4) for the drug or biological; and“(ii) in 2005 and subsequent years, the amount provided under section 1847A for the drug or biological.”.(b) GAO Study of Medicare Payment for Inhalation Therapy.—(1) Study.—The Comptroller General of the United States shall conduct a study to examine the adequacy of current reimbursements for inhalation therapy under the medicare program.(2) Report.—Not later than 1 year after the date of the enactment of this Act, the Comptroller General shall submit 117 STAT. 2256 to Congress a report on the study conducted under paragraph (1).